Real-time enrollment status for this persistent corneal epithelial defect clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:06 PM UTC
| NCT Number | NCT07886268 |
| Recruiting Status | Recruiting |
| Condition | Persistent Corneal Epithelial Defect |
| Phase | PHASE2 |
| Target Enrollment | 32 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Tarsus Pharmaceuticals, Inc. |
| Last Updated on CT.gov | October 21, 2026 (22 hours ago) |
As of October 21, 2026: Clinical trial NCT07886268 is currently recruiting participants. This phase2 study for persistent corneal epithelial defect is actively seeking new participants at 10 locations across the United States. The study is sponsored by Tarsus Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07886268 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07886268 was last updated 22 hours ago (October 21, 2026). HelloStudys verifies this status automatically.